For Native Advertising, FDA/FTC Rules Still Apply, Attorneys Stress
This article was originally published in The Gray Sheet
Native advertising, which is advertising designed to blend in with nearby non-advertising content, is becoming more popular with the growth of digital marketing. But device-makers need to be cautious about using the medium in compliance with federal promotional rules.
You may also be interested in...
A collaboration between Novo and Fauna will look at animal hibernation and genetic sequencing for hints toward novel therapies for obesity. Pfizer will use Insilico’s machine learning technology in target validation.
The introduction of gene therapies has been the highest-profile new modality to reach the market, but new RNA-based therapeutics hold significant potential and could be more accessible for patients. Scrip reviews the leading drug developers in this space.